GLP-influences food and drug reward

Current Opinion in Behavioral Sciences

Volumn 9, Issue , 2016, Pages 66-70

  Hayes, Matthew R ^a   Schmidt, Heath D ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; HORMONE; LIRAGLUTIDE; NEUROPEPTIDE;

ALCOHOL CONSUMPTION; CENTRAL NERVOUS SYSTEM; DRUG DEPENDENCE; EVOLUTIONARY ADAPTATION; FEEDING BEHAVIOR; FOOD DEPRIVATION; HUMAN; HUNGER; HYPERPHAGIA; INSTRUMENTAL CONDITIONING; LATERAL HYPOTHALAMUS; MOTIVATION; NONHUMAN; NUCLEUS ACCUMBENS; NUCLEUS ACCUMBENS CORE; OBESITY; PARABRACHIAL NUCLEUS; REVIEW; REWARD; VENTRAL HIPPOCAMPUS; VENTRAL TEGMENTUM;

EID: 84958178959     PISSN: None     EISSN: 23521546     Source Type: Journal    
DOI: 10.1016/j.cobeha.2016.02.005     Document Type: Review

References (45)

1. Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., Mullany E.C., Biryukov S., Abbafati C., Abera S.F., Abraham J.P., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet 2014, 384:766-781.
2. McAllister E.J., Dhurandhar N.V., Keith S.W., Aronne L.J., Barger J., Baskin M., Benca R.M., Biggio J., Boggiano M.M., Eisenmann J.C., Elobeid M., et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 2009, 49:868-913.
3. Thomas D.M., Bouchard C., Church T., Slentz C., Kraus W.E., Redman L.M., Martin C.K., Silva A.M., Vossen M., Westerterp K., Heymsfield S.B. Why do individuals not lose more weight from an exercise intervention at a defined dose? An energy balance analysis. Obes Rev 2012, 13:835-847.
4. Rosenbaum M., Kissileff H.R., Mayer L.E., Hirsch J., Leibel R.L. Energy intake in weight-reduced humans. Brain Res 2010, 1350:95-102.
5. Grill H.J. Distributed neural control of energy balance: contributions from hindbrain and hypothalamus. Obesity (Silver Spring) 2006, 14:216S-221S.
6. Grill H.J., Hayes M.R. Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab 2012, 16:296-309.
7. Hayes M.R., Mietlicki-Baase E.G., Kanoski S.E., De Jonghe B.C. Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose. Annu Rev Nutr 2014, 34:237-260.
8. Hayes M., Chustek M., Heshka S., Wang Z., Pietrobelli A., Heymsfield S.B. Low physical activity levels of modern homo sapiens among free-ranging mammals. Int J Obes (Lond) 2005, 29:151-156.
9. Berthoud H.R. The neurobiology of food intake in an obesogenic environment. Proc Nutr Soc 2012, 1-10.
10. Mai B., Sommer S., Hauber W. Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens. Cogn Affect Behav Neurosci 2012, 12:74-84.
11. Haase L., Green E., Murphy C. Males and females show differential brain activation to taste when hungry and sated in gustatory and reward areas. Appetite 2011, 57:421-434.
12. Nader K., Bechara A., van der Kooy D. Neurobiological constraints on behavioral models of motivation. Annu Rev Psychol 1997, 48:85-114.
13. Arana F.S., Parkinson J.A., Hinton E., Holland A.J., Owen A.M., Roberts A.C. Dissociable contributions of the human amygdala and orbitofrontal cortex to incentive motivation and goal selection. J Neurosci 2003, 23:9632-9638.
14. Corrigall W.A., Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl) 1989, 99:473-478.
15. Corrigall W.A., Herling S., Coen K.M. Evidence for a behavioral deficit during withdrawal from chronic nicotine treatment. Pharmacol Biochem Behav 1989, 33:559-562.
16. Hopkins T.J., Rupprecht L.E., Hayes M.R., Blendy J.A., Schmidt H.D. Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats. Neuropsychopharmacology 2012, 37:2310-2321.
17. Fowler C.D., Lu Q., Johnson P.M., Marks M.J., Kenny P.J. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011, 471:597-601.
18. Zoli M., Picciotto M.R. Nicotinic regulation of energy homeostasis. Nicotine Tob Res 2012, 14:1270-1290.
19. Grebenstein P.E., Thompson I.E., Rowland N.E. The effects of extended intravenous nicotine administration on body weight and meal patterns in male Sprague-Dawley rats. Psychopharmacology (Berl) 2013, 228:359-366.
20. Hayes M.R., Mietlicki-Baase E.G., Kanoski S.E., De Jonghe B.C. Incretins and amylin: neuroendocrine communication between the gut, pancreas and brain in control of food intake and blood glucose. Annu Rev Nutr 2014, 34:237-260.
21. Hayes M.R., Skibicka K.P., Grill H.J. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-receptor stimulation. Endocrinology 2008, 149:4059-4068.
22. Kinzig K.P., D'Alessio D.A., Seeley R.J. The diverse roles of specific glp-receptors in the control of food intake and the response to visceral illness. J Neurosci 2002, 22:10470-10476.
23. Knauf C., Cani P.D., Perrin C., Iglesias M.A., Maury J.F., Bernard E., Benhamed F., Gremeaux T., Drucker D.J., Kahn C.R., Girard J., et al. Brain glucagon-like peptide-increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 2005, 115:3554-3563.
24. Schick R.R., Zimmermann J.P., vorm Walde T., Schusdziarra V. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1427-R1435.
25. Kanoski S.E., Rupprecht L.E., Fortin S.M., De Jonghe B.C., Hayes M.R. The role of nausea in food intake and body weight suppression by peripheral glp-receptor agonists, exendin-and liraglutide. Neuropharmacology 2012, 62:1916-1927.
26. Kanoski S.E., Fortin S.M., Arnold M., Grill H.J., Hayes M.R. Peripheral and central glp-receptor populations mediate the anorectic effects of peripherally administered glp-receptor agonists, liraglutide and exendin-4. Endocrinology 2011, 152:3103-3112.
27. Alhadeff A.L., Rupprecht L.E., Hayes M.R. Glp-neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 2012, 153:647-658.
28. Dickson S.L., Shirazi R.H., Hansson C., Bergquist F., Nissbrandt H., Skibicka K.P. The glucagon-like peptide 1 (glp-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic glp-receptors. J Neurosci 2012, 32:14.
29. Dossat A.M., Lilly N., Kay K., Williams D.L. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci 2011, 31:14453-14457.
30. Mietlicki-Baase E.G., Ortinski P.I., Reiner D.J., Sinon C.G., McCutcheon J.E., Pierce R.C., Roitman M.F., Hayes M.R. Glucagon-like peptide-receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic ampa/kainate signaling. J Neurosci 2014, 34:6985-6992.
31. Mietlicki-Baase E.G., Ortinski P.I., Rupprecht L.E., Olivos D.R., Alhadeff A.L., Pierce R.C., Hayes M.R. The food intake-suppressive effects of glucagon-like peptide-receptor signaling in the ventral tegmental area are mediated by ampa/kainate receptors. Am J Physiol Endocrinol Metab 2013.
32. Alhadeff A.L., Grill H.J. Hindbrain nucleus tractus solitarius glucagon-like peptide-receptor signaling reduces appetitive and motivational aspects of feeding. Am J Physiol Regul Integr Comp Physiol 2014, 307:R465-R470.
33. Richard J.E., Anderberg R.H., Goteson A., Gribble F.M., Reimann F., Skibicka K.P. Activation of the glp-receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system. PLOS ONE 2015, 10:e0119034.
34. Moran T.H. Gut peptide signaling in the controls of food intake. Obesity (Silver Spring) 2006, 14:250S-253S.
35. Bartness T.J., Vaughan C.H., Song C.K. Sympathetic and sensory innervation of brown adipose tissue. Int J Obes (Lond) 2010, 34:S36-S42.
36. Mordes J.P., Liu C., Xu S. Medications for weight loss. Curr Opin Endocrinol Diabetes Obes 2015, 22:91-97.
37. Engel J.A., Jerlhag E. Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy. CNS drugs 2014, 28:875-886.
38. Skibicka K.P. The central glp-1: implications for food and drug reward. Front Neurosci 2013, 7:181.
39. Schmidt H.D., Mietlicki-Baase E.G., Ige K.Y., Maurer J.J., Reiner D.J., Zimmer D.J., Van Nest D.S., Guercio L.A., Wimmer M.E., Olivos D.R., De Jonghe B.C., et al. Glucagon-like peptide-receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine. Neuropsychopharmacology 2015.
40. Sclafani A. Oral and postoral determinants of food reward. Physiol Behav 2004, 81:773-779.
41. Kanoski S.E., Davidson T.L. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav 2011, 103:59-68.
42. Maniscalco J.W., Zheng H., Gordon P.J., Rinaman L. Negative energy balance blocks neural and behavioral responses to acute stress by "silencing" central glucagon-like peptide 1 signaling in rats. J Neurosci 2015, 35:10701-10714.
43. Maniscalco J.W., Kreisler A.D., Rinaman L. Satiation and stress-induced hypophagia: examining the role of hindbrain neurons expressing prolactin-releasing peptide or glucagon-like peptide 1. Front Neurosci 2012, 6:199.
44. Rinaman L. Interoceptive stress activates glucagon-like peptide-neurons that project to the hypothalamus. Am J Physiol 1999, 277:R582-R590.
45. Chan S.W., Lin G., Yew D.T., Yeung C.K., Rudd J.A. Separation of emetic and anorexic responses of exendin-4, a glp-receptor agonist in suncus murinus (house musk shrew). Neuropharmacology 2013, 70:141-147.